Cargando...
EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors (statins) essentially reduces IHD morbidity and mortality. The lower serum level of low density lipopro...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Stolichnaya Izdatelskaya Kompaniya
2016-01-01
|
| Colección: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
| Materias: | |
| Acceso en línea: | https://www.rpcardio.com/jour/article/view/820 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|